Table 1 Basic information and clinical features of 64 cases of COVID-19 in Wenzhou Table 1 Basic information and clinical features of 64 cases of COVID-19 in Wenzhou
Characteristics Value
Total 64
Age(year) Median
44
≤20 1/64(1.56%)
20-60 58/64(90.63%)
≥60 5/64(7.81%)
Gender
Male 36/64(56.25%)
Female 28/64(43.75%)
Generation
1 (been to Wuhan in last 14 days) 33/64(51.56%)
2 (close contact to 1) 25/64(39.06%)
3 (close contact to 2) 6/64(9.38%)
Severity
Light 51/64(79.69%)
Severe 11/64(17.19%)
Critical 2/64(3.12%)
Latency(62 cases had close contact history)(days) Latency(62 cases had close contact history)(days)
Mean of latency 3.44
Longest latency 14
Shortest latency 1
Discharge (till Feb 14) 20
Of Light 13/51(25.49%)
Of Severe 6/11(54.55%)
Of Critical 1/2(50%)
Average hospital stay(day) 21.1
Triple therapy (Interferon, Lopinavir/ritonavir, Abidor) 8 days/course
Glucocorticoid 9/64(14.06%)
Antibiotic use 19/64(29.69%)
Average of course of antibiotic use(days) 8
Average of PCR transform to negative(days) 12.8
Temperature (℃) (Mean±SD) 38.1±0.85**
Fever 59/64 (92.19%)
Weakness 39/64 (60.9%)
Muscular soreness 5/64 (7.8%)
Lung Symptoms (by Chest Computer Tomographic) 62/64 (96.9%)
Pneumonia 62
Lungs involvement (Both) 61
Ground-glass opacity 48
Consolidation 42
Respiratory Symptoms 45/64 (70.3%)
Dry Cough 41
Cough and expectoration 23
Shortness of breath 18
Pharyngalgia 10
Bloody phlegm 4
Nasal obstruction 4
Yellow spectrum 3
Gastrointestinal symptoms 28/64 (43.8%)
Diarrhea 14
Nausea 13
Vomit 8
No symptoms (including no fever)
Secondary infection 15
Basic disease 27/64
Smoke None
Hypertension 20/64
Chronic Liver disease 7